Skip to main content
. 2017 Sep;5(17):340. doi: 10.21037/atm.2017.07.01

Table 1. Anthropometric measurement for individuals with diabetes Khartoum (N=310).

Factor/covariate DFU (%) No DFU (%) Total (%) P value
Gender 0.608
   Men 35 (62.5) 147 (57.7) 182 (58.7)
   Women 21 (37.5) 107 (42.3) 128 (41.3)
Age, mean ± SD, (years) 57.7 59 58.7 0.401
BMI, mean ± SD 25.7 26.3 26.2 0.303
Family history 0.608
   Negative 18 (32.1) 87 (34.4) 105 (34.0)
   Positive 38 (67.9) 167 (65.6) 205 (66.0)
Duration of diabetes 0.0018
   Up to 5 years 0 (0) 34 (13.5) 34 (11.0)
   6 to 10 years 5 (8.9) 47 (18.5) 52 (16.8)
   11 to 20 years 23 (41.1) 94 (36.9) 117 (37.7)
   More than 20 years 28 (50.0) 79 (31.2) 107 (34.5)
Hypertension 0.672
   Negative 31 (55.4) 130 (51.2) 161 (51.9)
   Positive 25 (44.6) 124 (48.8) 149 (48.1)
Cholesterol (mean) 171.5 157.6 162.9 0.359
HbA1c (mean) 9.84 10.15 10.09 0.396
Triglycerides (mean) 149.9 142.5 143.9 0.627
HDL (mean) 38.21 37.06 37.26 0.599
LDL (mean) 122.35 113.69 115.2 0.998
Retinopathy 0.342
   Both eyes 41 (73.2) 162 (63.9) 203 (65.6)
   Left eye 6 (10.7) 28 (11.0) 34 (10.9)
   Right eye 1 (1.8) 20 (7.8) 21 (6.8)
   Negative 8 (14.3) 44 (17.3) 52 (16.7)
Albuminuria 0.480
   Negative 35 (62.5) 174 (68.5) 209 (67.4)
   Positive 21 (37.5) 80 (31.5) 101 (32.6)
Neuropathy 0.140
   Negative 10 (17.9) 73 (28.6) 83 (26.8)
   Positive 46 (82.1) 181 (71.4) 229 (73.2)

No significant association was found between DFU group and other metabolic factors like hypertension, albuminuria, retinopathy, neuropathy, HbA1c, cholesterol, HDL, LDL and triglyceride when using ANOVA testing. Only duration of diabetes was statistically significant.